Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Noxafil concentrated injection PI 17 Oct 2018
Noxafil concentrated injection CMI 17 Oct 2018
Zeklen PI 17 Oct 2018
Zeklen CMI 17 Oct 2018
Vytorin PI 17 Oct 2018

New products

Product name Type Date released
Regaine PI 17 Oct 2018
Nicorette Lozenge PI 17 Oct 2018
Ondansetron Mylan ODT PI 17 Oct 2018
Tenofovir/Emtricitabine 300/200 APOTEX CMI 10 Oct 2018
Tenofovir/Emtricitabine 300/200 APOTEX PI 10 Oct 2018